drugset / Trial / NCT04735913

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

NCT04735913

Phase 0 Unknown 81 enrolled Zhongnan Hospital
RandomizedParallel-groupOpen-labelOther

Summary

1. To explore the relationship between the changes of plasma concentration of abiraterone acetate after taken orally on fasting or postprandial and gene polymorphism. 2. Study of drug Metabolite profiling after oral administration of abiraterone acetate on fasting and postprandial in Chinese adults.

Timeline

Start
2020-05-05
Primary completion
2020-08-20
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Abiraterone acetate Small molecule 250 mg Oral

Indications

No indication recorded.